Groupe la Francaise »

Biogen Idec shares owned by Groupe la Francaise

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Groupe la Francaise from 13F filings

Historical chart of Groupe la Francaise investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Groupe la Francaise consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Groupe la Francaise

Quarter filed Position value Share count Share price at filing
2026-06-30 $112k 519 216.06

More positions owned by Groupe la Francaise

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Totalenergies Se Act (TTE)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Alphabet Cap Stk Cl C (GOOG)
Astrazeneca Ord (AZN)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Meta Platforms Cl A (META)
Cgi Cl A Sub Vtg (GIB)

View all positions for Groupe la Francaise

Top funds holding Biogen Idec

FMR
BlackRock
PRIMECAP Management Company
Vanguard Capital Management
State Street Corporation
Vanguard Portfolio Management
Geode Capital Management
Wellington Management Company
Norges Bank Investment Management
Morgan Stanley
AQR Capital Management
Jpmorgan Chase & Co
Invesco
Susquehanna International
UBS Group

View all funds holding Biogen Idec